SCHEMBL5147522

SCHEMBL5147522

CC(C)(C)c1ccc(CN(Cc2ccc(NS(C)(=O)=O)cc2)C(N)=S)cc1

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.63
EPHX2 P34913 1/20 0.55
NR1H4 Q96RI1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5674819 0.92 TRPV1 (0.57) TRPV1EPHX2NR1H4
SCHEMBL5674452 0.83 EPHX2 (0.54) TRPV1EPHX2NR1H4
SCHEMBL5674816 0.83 TRPV1 (0.55) TRPV1
SCHEMBL4890952 0.81 TRPV1 (0.50) TRPV1EPHX2NR1H4
SCHEMBL4890957 0.81 TRPV1 (0.50) TRPV1EPHX2NR1H4
SCHEMBL5313078 0.79
SCHEMBL5716171 0.78 TRPV1 (0.72) TRPV1EPHX2NR1H4
SCHEMBL1268701 0.77 TRPV1 (1.00) TRPV1
SCHEMBL117355 0.77 NR3C2 (0.67) TRPV1EPHX2NR1H4
SCHEMBL5674449 0.76 EPHX2 (0.52) TRPV1EPHX2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771162-A2 CAPSAICIN INHIBITORS FOR TREATING OBESITY AND RELATED DISORDERS NOVO NORDISK A/S (DK) 2007-04-11 EP disclosed
WO-2006007851-A2 CAPSAICIN INHIBITORS FOR TREATING OBESITY AND-RELATED DISORDERS NOVO NORDISK A/S (DK) 2006-01-26 WO disclosed